HSPA9 and ovarian cancer: To determine whether miR-200b/c could regulate the expression of mortalin in ovarian cancer cells, cisplatin-sensitive A2780S and cisplatin-resistant A2780CP ovarian cancer cell lines were chosen for further analysis.